GIVE MISS CALL ON :- +91 99774 99927

Tag Archives: Option tips

CAPITALSTARS – भारत में खरीदारी के लिए बेहतर हैं ये स्‍टॉक: 11 DEC 2018

The NSE benchmark Nifty not only opened with a gap-down, but the bears got momentum on the downside as the day progressed and the index ended below the important psychological 10,500 mark and near the lowest level of the day. The price action formed a small body negative candle which resembles ‘high wave’ candle with

CAPITALSTARS – MCX COMMODITY MORNING MARKET NEWS UPDATES – 10 DEC 2018

BULLION:- Gold traded firm near a five-month peak hit early on Monday, supported by a disappointing U.S. jobs data that fuelled speculation that the Federal Reserve may stop raising interest rates sooner than expected. The dollar slipped against the yen and the euro, while stocks extended their slump as worries over U.S.-China trade tensions battered

CAPITALSTARS- INDIAN EQUITY MARKET OUTLOOK – 07 DEC 2018

Nifty likely to open higher. Indian Indices: Trends on SGX Nifty indicate that the index will open 51 points (0.48 percent) higher in India. Nifty futures were trading around 10,675 on the Singaporean exchange. Global Market: • Asian markets: Asian markets are higher today as Japanese and Hong Kong shares show gains. The Nikkei 225

CAPITALSTARS – MCX COMMODITY MORNING MARKET NEWS UPDATES – 06 DEC 2018

BULLION:- U.S. stock futures tumbled on Thursday and Asian markets followed after Canadian authorities arrested a top executive of Chinese tech giant Huawei Technologies, fanning fears of further tensions between China and the United States. MKTS/GLOB The dollar, which has enjoyed an unrivalled surge against its peers this year, will be undermined in 2019 on

CAPITALSTARS- INDIAN EQUITY MARKET OUTLOOK – 05 DEC 2018

A morning walk down Dalal Street | RBI may maintain status-quo on rates with support for Nifty at 10,747. Indian Indices: It looks like the market has already priced in the uncertainty the way it has been moving in a narrow range since last Friday. Global Market: • Asian markets: Asian markets are lower today

TOP CORPORATE NEWS- 04 DEC 2018

Alembic Pharma subsidiary gets USFDA nod for Glycopyrrolate tablets Alembic Pharmaceuticals Ltd (Alembic), in a release to the exchanges on Tuesday, announced that its wholly-owned subsidiary Orit Laboratories LLC has received approval from the USFDA for its ANDA Glycopyrrolate tablets USP, 1 mg and 2 mg. According to IQVIA, Glycopyrrolate Tablets USP, 1 mg and

CapitalStars FORUM